Form 4: Guardant Health Director Vijaya Gadde Increases Stake Through RSU Vesting

Guardant Health, Inc. Director Vijaya Gadde has increased her beneficial ownership of common stock by 6,674 shares through the vesting of Restricted Stock Units.

Summary

• Vijaya Gadde, a Director at Guardant Health, Inc. (GH), acquired 6,674 shares of common stock.
• The acquisition occurred on June 12, 2025, through the exercise or conversion of derivative securities (Restricted Stock Units).
• The transaction price for the acquired shares was $0, indicating a vesting event rather than a purchase.
• Following this transaction, Ms. Gadde's direct beneficial ownership of Guardant Health common stock stands at 24,314 shares.
• The Restricted Stock Units (RSUs) vested in full on the one-year anniversary of their grant date, June 12, 2024, or the date of the next annual stockholders meeting, whichever is earlier.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director increasing their beneficial ownership, even through RSU vesting, generally signals continued alignment with shareholder interests and confidence in the company. It's a routine compensation event, not a direct open-market purchase, which tempers the positive impact slightly.

Positives

• Increased beneficial ownership by a director, Vijaya Gadde, aligning her interests further with shareholders.
• The acquisition of 6,674 shares of common stock demonstrates continued commitment from a key board member.

Future Outlook

This document, an SEC Form 4, does not provide forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This SEC Form 4 filing details a routine insider transaction (vesting of Restricted Stock Units) for a director of Guardant Health, Inc., a company operating in the precision oncology and liquid biopsy industry. Such transactions are common compensation events for executives and board members across various industries and do not inherently reflect broader industry trends.

Related Party Transactions

• The acquisition of common stock by Director Vijaya Gadde through the vesting of Restricted Stock Units constitutes a related party transaction, as it involves a company insider and their compensation.

Stakeholder Impact

• Shareholders: Increased insider ownership can be viewed positively as it aligns the director's financial interests more closely with those of the shareholders.
• Employees: The vesting of RSUs is a standard component of executive compensation, reflecting typical incentive structures.

Next Steps

• The vesting schedule indicates that the RSUs vested on the one-year anniversary of the grant date (June 12, 2024) or the date of the next annual stockholders meeting, whichever is earlier, implying future vesting events may occur based on the original grant terms.

Key Dates

Keywords

Guardant Health, GH, Vijaya Gadde, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Beneficial Ownership, Director Stock Acquisition